Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease. - Wikidata - wikimedia - TriplyDB

Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease.

Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease.

http://www.wikidata.org/entity/Q37285513

about

The rise of mitochondria in medicine Is 2D speckle tracking echocardiography useful for detecting and monitoring myocardial dysfunction in adult m.3243A>G carriers? - a retrospective pilot study Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease.Novel MTND1 mutations cause isolated exercise intolerance, complex I deficiency and increased assembly factor expression.Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults Preliminary Evaluation of Clinician Rated Outcome Measures in Mitochondrial Disease.Exercise as a therapeutic strategy for primary mitochondrial cytopathies.Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients Psychological Stress and Mitochondria: A Conceptual Framework.Monitoring clinical progression with mitochondrial disease biomarkers.Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease.

P2860

Q26740014-A99BFED5-624F-4E56-BB57-2E2B8DE15E6D Q30362604-6EA87D28-C26D-4D80-88F9-74EF9D0B2BFB Q31165571-ED74D8AE-B322-4ECF-A3EB-5A1574858D08 Q36184704-793CBCED-73CD-43B6-AEA0-A92D6FFE2583 Q37210464-8AB29120-B688-4BFA-8C7B-51E0ABC65A67 Q37225729-C0D44AC1-116A-4DEA-AF6B-05FA0B326104 Q37610535-BDDDEC40-F9DD-479E-AB13-7C631420328E Q38227791-F7535318-234C-46C0-97B0-991ABDFB4358 Q41544135-BCFD6587-596D-476E-8805-A167D4508272 Q47550262-75344704-FF7F-49CE-BE23-692F1C9C785E Q47713915-6149E2F7-12E7-4957-B2C1-76F9E1A4D8B9 Q50072070-1878E46C-1971-4B9C-B018-505C9AA3C557

P2860

Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease.

http://www.wikidata.org/entity/Q37285513

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Defining cardiac adaptations a ...... related mitochondrial disease.

@en

Defining cardiac adaptations a ...... related mitochondrial disease.

@nl

type

label

Defining cardiac adaptations a ...... related mitochondrial disease.

@en

Defining cardiac adaptations a ...... related mitochondrial disease.

@nl

prefLabel

Defining cardiac adaptations a ...... related mitochondrial disease.

@en

Defining cardiac adaptations a ...... related mitochondrial disease.

@nl

P1433

Q37285513-E1E2B760-426A-4475-8667-A7D31CBFAEC7

P1476

Q37285513-09201E12-0B4D-4188-B1DD-9DFB64860B6F

P2093

Q37285513-171B81E6-8BA8-4EBE-9894-8FAC936FE55B

Q37285513-2B9BE7C3-8F4C-46FC-8A39-7F726B744108

Q37285513-36B355F1-0D89-4EDD-8F54-24CF181F2ACD

Q37285513-4EF3F68B-465C-4542-BDEA-07845D7EA615

Q37285513-7E18F1C3-990D-454C-BB7E-53EEAC65DBA0

Q37285513-BC99FBF9-C0E5-4425-B679-6035478E3181

Q37285513-E0569840-50A7-4BE8-8E06-C3E1DB4031DA

Q37285513-E74BD266-48B5-4D40-8B32-68DF899A34C8

Q37285513-FCD5F00C-2C37-4943-88AB-1672C11A2BAC

P2860

Q37285513-0FFEBA64-57D0-4CB1-B100-784D7DAC29B7

Q37285513-104B105E-E93A-48C6-8DD7-8A420C811EBA

Q37285513-14D8CF8E-631C-4406-A36C-A8145745A635

Q37285513-1AA7BBC0-B749-42EF-8EE1-E0DC74F8F051

Q37285513-2002AF70-AE6D-4351-A763-C7BEDE0244BC

Q37285513-2AC2D7E0-0182-4333-B94B-9C079FED08C5

Q37285513-2B5BE953-41FB-4FDC-AB03-FCBFA4DE4F64

Q37285513-2B8B6B6B-6A62-4F18-B302-7E2AE6F4F421

Q37285513-305351FE-FF45-42D5-ACA9-C23499BEE046

Q37285513-32C6C1C5-A715-4F49-9498-121D71C18AC8

P304

Q37285513-71E08391-07FE-48C1-A891-28C1AF158517

P31

Q37285513-095A5D89-C3D3-4DAA-B252-B7BD23F97EFF

P356

Q37285513-9AD7A386-9117-4137-B42D-3C7FE1FFA930

P433

Q37285513-ED998CC8-AA8F-4E1F-B12E-040807135365

P478

Q37285513-220D3A3E-8543-4FD6-8058-923E139E01F4

P50

Q37285513-180F0112-43E7-4472-838A-284EF30DA51F

Q37285513-29106A91-6AA9-4FAD-A9B4-53094EBA6AC9

Q37285513-3113DA97-12E3-48D2-8C42-8A328271BC79

Q37285513-3264D99B-61FA-47BA-B823-FF31D25A3080

Q37285513-6487396D-4590-420B-9DA3-0DD28AFD31D1

Q37285513-6EE99DC7-2216-48F4-BE6F-74BBEB06C8BA

Q37285513-9FE4391E-1A5C-411E-B5EF-3C93D1B20931

Q37285513-A752151E-C65E-4E18-83C0-A5BEA185CE85

Q37285513-AAF623CA-C83C-49AB-9096-E454E39D5FF2

P577

Q37285513-F1660A2F-57AB-4A85-AC86-114953FD791C

P5875

Q37285513-CACC2216-0D2C-4811-BFED-D0F10A537430

P698

Q37285513-EF34B396-938C-40BD-908D-CF51D909EB29

P921

Q37285513-F337D9BB-5F2A-4866-87A2-B0A7B6CFA1BE

P932

Q37285513-6F53DA55-F6C2-412E-A2B5-C9FBDC640960

P356

J.IJCARD.2013.05.062

P1433

International Journal of Cardiology

P1476

Defining cardiac adaptations a ...... -related mitochondrial disease

@en

P2093

Bernard D Keavney

http://www.w3.org/2001/XMLSchema#string

Guy A MacGowan

http://www.w3.org/2001/XMLSchema#string

Jacek J Klawe

http://www.w3.org/2001/XMLSchema#string

Jane H Newman

http://www.w3.org/2001/XMLSchema#string

John P Bourke

http://www.w3.org/2001/XMLSchema#string

Julia L Newton

http://www.w3.org/2001/XMLSchema#string

Kieren G Hollingsworth

http://www.w3.org/2001/XMLSchema#string

Pawel Zalewski

http://www.w3.org/2001/XMLSchema#string

Robert W Taylor

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment for mitochondrial disorders

Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G.

Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts

Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management.

Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease.

Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings.

Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation.

Impaired cardiovascular function in primary biliary cirrhosis.

Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects.

Exercise intolerance, lactic acidosis, and abnormal cardiopulmonary regulation in exercise associated with adult skeletal muscle cytochrome c oxidase deficiency.

P304

3599-3608

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJCARD.2013.05.062

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

168

http://www.w3.org/2001/XMLSchema#string

P50

Michael I Trenell

Andrew M. Blamire

Charlotte L Alston

Andrew M Schaefer

Doug M Turnbull

Robert McFarland

Gráinne S. Gorman

Matthew G D Bates

Djordje G Jakovljevic

P577

2013-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237069259

http://www.w3.org/2001/XMLSchema#string

P698

23742928

http://www.w3.org/2001/XMLSchema#string

P921

P932

3819621

http://www.w3.org/2001/XMLSchema#string